Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gordon J Freeman

Showing results (21-30 of 348) with videos related to

Pageof 35
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liverHolly Maier, Masanori Isogawa, Gordon J Freeman, et al.
Cancer Research|May 2, 2013
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumorsJaikumar Duraiswamy, Karen M Kaluza, Gordon J Freeman, et al.
The Journal of Experimental Medicine|June 9, 2004
CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesionAnn E Herman, Gordon J Freeman, Diane Mathis, et al.
Trends in Immunology|January 26, 2021
VISTA: A Mediator of Quiescence and a Promising Target in Cancer ImmunotherapyLong Yuan, Jahnavi Tatineni, Kathleen M Mahoney, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|August 4, 2022
A Comparison of Murine PD-1 and PD-L1 Monoclonal AntibodiesMelissa T Bu, Long Yuan, Alyssa N Klee, et al.
The American Journal of Surgical Pathology|July 5, 2006
Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphomaDavid M Dorfman, Julia A Brown, Aliakbar Shahsafaei, et al.
Nature Immunology|February 17, 2007
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infectionArlene H Sharpe, E John Wherry, Rafi Ahmed, et al.
Human Pathology|July 27, 2010
The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasmsDavid M Dorfman, Jason L Hornick, Aliakbar Shahsafaei, et al.
Annual Review of Immunology|March 2, 2016
Coinhibitory Pathways in Immunotherapy for CancerSusanne H Baumeister, Gordon J Freeman, Glenn Dranoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2008
Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockadeShawn D Blackburn, Haina Shin, Gordon J Freeman, et al.
Pageof 35

Showing results (21-30 of 348) with videos related to

Sort By:
Pageof 35
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2007
PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liverHolly Maier, Masanori Isogawa, Gordon J Freeman, et al.
Cancer Research|May 2, 2013
Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumorsJaikumar Duraiswamy, Karen M Kaluza, Gordon J Freeman, et al.
The Journal of Experimental Medicine|June 9, 2004
CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesionAnn E Herman, Gordon J Freeman, Diane Mathis, et al.
Trends in Immunology|January 26, 2021
VISTA: A Mediator of Quiescence and a Promising Target in Cancer ImmunotherapyLong Yuan, Jahnavi Tatineni, Kathleen M Mahoney, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|August 4, 2022
A Comparison of Murine PD-1 and PD-L1 Monoclonal AntibodiesMelissa T Bu, Long Yuan, Alyssa N Klee, et al.
The American Journal of Surgical Pathology|July 5, 2006
Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphomaDavid M Dorfman, Julia A Brown, Aliakbar Shahsafaei, et al.
Nature Immunology|February 17, 2007
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infectionArlene H Sharpe, E John Wherry, Rafi Ahmed, et al.
Human Pathology|July 27, 2010
The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasmsDavid M Dorfman, Jason L Hornick, Aliakbar Shahsafaei, et al.
Annual Review of Immunology|March 2, 2016
Coinhibitory Pathways in Immunotherapy for CancerSusanne H Baumeister, Gordon J Freeman, Glenn Dranoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2008
Selective expansion of a subset of exhausted CD8 T cells by alphaPD-L1 blockadeShawn D Blackburn, Haina Shin, Gordon J Freeman, et al.
Pageof 35